We are live on !
Find out more
HA
Hamel Associates Portfolio holdings
AUM
$363M
Turnover
15.96%
1-Year Est. Return
24.39%
This Fund
S&P 500
This Quarter Est. Return
+2.44%
1 Year Est. Return
+24.39%
3 Year Est. Return
+50.64%
5 Year Est. Return
+68.03%
10 Year Est. Return
+174.56%
AUM
$363M
AUM Growth
+$12.1M
(+3.5%)
Cap. Flow
+$9.6M
Cap. Flow % of AUM
Cap. Flow %
2.64%
Top 10 Holdings %
Top 10 Hldgs %
41.34%
Holding
94
New
13
Increased
21
Reduced
43
Closed
2
Avg Time Held
5.9
years
Top 10 Avg Time Held
4.8
years
Top 20 Avg Time Held
5.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
|
+$11.7M |
| 2 |
HONA
Honeywell Aerospace
HONA
|
+$3.19M |
| 3 |
Huntington Ingalls Industries
HII
|
+$1.79M |
| 4 |
Abbott
ABT
|
+$1.59M |
| 5 |
Kroger
KR
|
+$321K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$2.94M |
| 2 |
Verizon
VZ
|
+$1.44M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$1.11M |
| 4 |
Bank of New York Mellon
BNY
|
+$957K |
| 5 |
Apple
AAPL
|
+$879K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.33% |
| 2 | Healthcare | 14.16% |
| 3 | Consumer Staples | 11.69% |
| 4 | Financials | 10.3% |
| 5 | Technology | 9.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Schwab International Dividend Equity ETF
SCHY
$2.69B
| $25.7M | 7.08% |
808,765
-12,203
| -1% | -$394K |
2023 Q3
11 quarters
|
|
|
2
Apple
AAPL
$5.03T
| $17.2M | 4.74% |
59,477
-3,072
| -5% | -$879K |
2013 Q4
50 quarters
|
|
3
Johnson & Johnson
JNJ
$658B
| $16.5M | 4.55% |
64,967
-584
| -0.9% | -$136K |
2013 Q4
50 quarters
|
|
|
4
Alphabet (Google) Class C
GOOG
$3.42T
| $16.5M | 4.54% |
46,642
-3,104
| -6% | -$1.11M |
2022 Q4
14 quarters
|
|
5
Walmart Inc
WMT
$980B
| $15.5M | 4.28% |
137,247
-2,980
| -2% | -$370K |
2013 Q4
50 quarters
|
|
6
Chubb
CB
$139B
| $12.2M | 3.38% |
35,931
-319
| -0.9% | -$104K |
2020 Q1
25 quarters
|
|
7
Merck
MRK
$369B
| $11.9M | 3.28% |
92,513
-288
| -0.3% | -$33.7K |
2013 Q4
50 quarters
|
|
|
8
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
$20.8B
| $11.7M | 3.22% |
+232,135
| New | +$11.7M |
2026 Q2
0 quarters
|
|
9
ExxonMobil
XOM
$764B
| $11.5M | 3.16% |
83,833
-3,046
| -4% | -$456K |
2013 Q4
50 quarters
|
|
|
10
Bank of New York Mellon
BNY
$99B
| $11.3M | 3.12% |
78,197
-7,003
| -8% | -$957K |
2023 Q4
10 quarters
|
|
11
ConocoPhillips
COP
$185B
| $9.5M | 2.62% |
91,424
-1,195
| -1% | -$142K |
2020 Q4
22 quarters
|
|
12
Procter & Gamble
PG
$374B
| $8.42M | 2.32% |
57,457
+458
| +0.8% | +$66.7K |
2013 Q4
50 quarters
|
|
13
Microsoft
MSFT
$3.88T
| $8.03M | 2.21% |
21,522
+440
| +2% | +$178K |
2013 Q4
50 quarters
|
|
14
Coca-Cola
KO
$405B
| $7.91M | 2.18% |
97,406
-100
| -0.1% | -$7.9K |
2013 Q4
50 quarters
|
|
15
Illinois Tool Works
ITW
$79.2B
| $7.87M | 2.17% |
29,101
-189
| -0.6% | -$49K |
2013 Q4
50 quarters
|
|
16
Chevron
CVX
$459B
| $7.53M | 2.08% |
45,454
-477
| -1% | -$88.8K |
2013 Q4
50 quarters
|
|
17
Amgen
AMGN
$252B
| $7.27M | 2% |
20,068
-60
| -0.3% | -$20.5K |
2016 Q2
40 quarters
|
|
18
iShares Treasury Floating Rate Bond ETF
TFLO
$7.24B
| $7.13M | 1.97% |
140,840
-13,550
| -9% | -$685K |
2023 Q4
10 quarters
|
|
19
iShares iBonds Dec 2028 Term Corporate ETF
IBDT
$4.13B
| $6.62M | 1.83% |
262,251
-617
| -0.2% | -$15.6K |
2023 Q1
13 quarters
|
|
20
SPDR Gold Trust
GLD
$130B
| $6.54M | 1.8% |
17,757
+50
| +0.3% | +$20.7K |
2013 Q4
50 quarters
|
|
21
iShares iBonds Dec 2027 Term Corporate ETF
IBDS
$4B
| $6.44M | 1.78% |
265,974
-6,702
| -2% | -$162K |
2022 Q4
14 quarters
|
|
22
Novartis
NVS
$304B
| $6.34M | 1.75% |
40,423
-132
| -0.3% | -$19.8K |
2013 Q4
50 quarters
|
|
23
Union Pacific
UNP
$181B
| $6.03M | 1.66% |
22,157
-55
| -0.2% | -$14.4K |
2013 Q4
50 quarters
|
|
24
Consolidated Edison
ED
$43.1B
| $5.74M | 1.58% |
51,867
| – | – |
2013 Q4
50 quarters
|
|
25
iShares iBonds Dec 2029 Term Corporate ETF
IBDU
$4.02B
| $5.69M | 1.57% |
245,615
-1,087
| -0.4% | -$25.2K |
2024 Q1
9 quarters
|
|
Similar funds
UFAC
WMA
AIA
Hamel Associates's Q2 2026 Portfolio in Review
As of Q2 2026, Hamel Associates held 94 positions worth $363M, up 3.5% from $351M the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Hamel Associates's Q2 2026 filing shows 13 new, 21 increased, 43 reduced and 2 closed positions. Its largest new stake was Vanguard Short-Term Inflation-Protected Securities Index Fund: 232,135 shares worth $11.7M. The largest sale was Honeywell, an estimated $2.94M.
By sector, the portfolio is most concentrated in Miscellaneous at 24% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Staples.
- Hamel Associates's largest Q2 2026 buy was Vanguard Short-Term Inflation-Protected Securities Index Fund: 232,135 shares worth $11.7M.
- Hamel Associates added most to Huntington Ingalls Industries in Q2 2026, an estimated $1.79M increase.
- Hamel Associates's biggest Q2 2026 reduction was Honeywell, cutting an estimated $2.94M.
- Hamel Associates fully exited Bristol-Myers Squibb in Q2 2026, selling an estimated $220K.
- Hamel Associates's ten largest holdings make up 41% of its $363M portfolio in Q2 2026.
- Hamel Associates opened 13 new positions and closed 2 in Q2 2026.
- Hamel Associates's portfolio value rose 3.5% quarter-over-quarter to $363M.
Based on Hamel Associates's 13F filing for Q2 2026, filed 27 Jul 2026.